- Investing Ideas
- German Pharmaceuticals & Biotech Top Stock Picks from Analysts
German Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
0 new
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Formycon
Market Cap: €325.2m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€18.40
7D
-4.0%
1Y
-26.3%
MPH Health Care
Market Cap: €99.8m
An investment company, engages in the healthcare business in Germany.
93M1
€23.60
7D
-1.3%
1Y
33.7%
Novogenia
Market Cap: €78.0m
Manufactures and sells personalized health products in global markets.
7V0
€6.50
7D
8.3%
1Y
-1.5%
Cantourage Group
Market Cap: €72.1m
Operates as a medical cannabis company in Europe and internationally.
HIGH
€5.78
7D
-1.0%
1Y
41.3%